MAIA Biotechnology Inc (MAIA)
AMEXHealth CareBiotechnologySnapshot 2026-11-04
$1.04-8.77%
Close 2026-11-05 · 1-day change
AMEXHealth CareBiotechnologySnapshot 2026-11-04
QuarterlyIQ Insights · MAIA
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|---|---|---|
| Revenues | |||||||
| Revenues | — | — | — | 0.0 | 0.0 | — | — |
| Total Revenues | — | — | — | 0.0 | 0.0 | — | — |
| Operating Expenses & Income | |||||||
| R&D Expenses | — | 0.5 | 10.0 | 11.1 | 8.9 | 3.5 | — |
| Other Operating Expenses, Total | — | 1.9 | (6.3) | 0.4 | 0.4 | (4.8) | — |
| Operating Income | (28.9) | (24.3) | (17.0) | (20.2) | (16.2) | (7.8) | — |
| Earnings from Continuing Operations | |||||||
| Interest Expense | — | — | 0.0 | 0.0 | 0.0 | 0.8 | — |
| Interest & Investment Income | — | — | 0.3 | 0.0 | 0.0 | 0.0 | — |
| Net Interest Expenses | — | — | — | (0.0) | 0.0 | 0.8 | — |
| EBT, Incl. Unusual Items | — | (22.4) | (23.3) | (19.8) | (15.8) | (12.6) | — |
| Income Tax Expense | — | 0.0 | — | — | — | — | — |
| Net Income | |||||||
| Minority Interest | — | — | — | — | — | (0.1) | — |
| Net Income | (26.8) | (22.4) | (23.3) | (19.8) | (15.8) | (12.6) | — |
| Per Share | |||||||
| Basic EPS | (0.44) | (0.70) | (1.05) | (1.49) | (1.75) | (2.37) | — |
| Diluted EPS | (0.44) | (0.70) | (1.05) | (1.49) | (1.75) | (2.37) | — |
| Basic Weighted Avg Shares | 60.8 | 32.1 | 22.2 | 13.3 | 9.3 | 5.3 | — |
| Diluted Weighted Avg Shares | 60.8 | 32.1 | 22.2 | 13.3 | 9.3 | 5.3 | — |
| Supplemental | |||||||
| EBIT | (28.9) | (24.3) | (17.0) | (20.2) | (16.2) | (7.8) | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.